Assessing seasonal influenza vaccine effectiveness
On 3 December 2015, ECDC hosts a technical meeting to discuss influenza vaccine effectiveness studies and how they can best meet public health needs as well as regulatory requirements.
First annual meeting of the European Reference Laboratory Network for Tuberculosis (ERLTB-Net)
Kick-off meeting and large capacity building workshop of the ERLTB-Net. The meeting was a place for information exchange, networking, analysis of ERLN-TB achievements and planning of future initiatives.
Addressing TB and MDR TB in high-priority countries
At this technical meeting, tuberculosis experts from high-incidence countries (Bulgaria, Estonia, Latvia, Lithuania and Romania) discussed ways in which ECDC can support with development and implementation of country strategies to prevent and control the disease.
1st Eastern Partnership Ministerial Conference on Tuberculosis and Multi-Drug Resistance Tuberculosis
High-level meeting to discuss the burden of TB and MDR TB and its elimination as a public health problem in the EU/EEA and Eastern Partnership countries.
Annual meeting of the European Influenza Surveillance Network, 2015
The ECDC annual meeting of the European Influenza Surveillance Network (EISN) prepared in collaboration with the EISN Coordination Committee, brought together epidemiological and virological surveillance contact points and representatives from reference laboratories from the 31 EU/EEA Member States as well as participants from EU pre-accession countries, Eastern European Neighbourhood Policy partner countries, the WHO Regional Office for Europe, and involved international institutions.
Meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis and Wolfheze Workshops
The 2015 meeting of the Joint ECDC/WHO Surveillance Network for Tuberculosis was held in The Hague, the Netherlands, on 26-27 May 2015. The meeting was organised jointly by the European Centre for Disease Prevention and Control (ECDC) and WHO/Europe for TB surveillance experts from WHO European region including European Union/European Economic Area (EU/EEA) Member States (MSs). The participants included 47 nominated contact points for TB surveillance from 42 countries, as well as experts from ECDC and WHO/Europe, WHO headquarters and country offices. In addition, experts from seven EU Enlargement Countries and from the KNCV TB Foundation (the Netherlands) attended the meeting as observers.
Vaccination in the EU: benefits and barriers, European Parliament Committee on the Environment, Public Health and Food Safety
Professor Mike Catchpole, Chief Scientist of ECDC, presented to the Environment, Public Health and Food Safety Committee of the European Parliament during an exchange of views on vaccination.
Understanding the association between narcolepsy and one of the 2009 adjuvanted influenza A (H1N1) vaccines
This meeting was designed to offer a place to exchange the latest information on into the development of narcolepsy following vaccination with one of the 2009 adjuvanted influenza A(H1N1) vaccines.